Twist Bioscience (TWST) SVP sells 1,070 shares in tax sell-to-cover transaction
Rhea-AI Filing Summary
Twist Bioscience Corp officer Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary, reported a sale of 1,070 shares of common stock on 2026-08-03 at $85.3212 per share. According to the footnote, this mandated "sell to cover" transaction funded tax withholding on vesting Restricted Stock Units and was not a discretionary trade. After the sale, Cho directly held 104,071 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,070 shares
Net Sell
1 txn
Insider
Cho Dennis
Role
See Remarks
Sold
1,070 shs ($91K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 1,070 | $85.3212 | $91K |
Holdings After Transaction:
Common Stock — 104,071 shares (Direct)
Footnotes (1)
- F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Key Figures
Shares sold: 1,070 shares
Sale price: $85.3212 per share
Shares held after: 104,071 shares
+1 more
4 metrics
Shares sold
1,070 shares
Common stock sold on 2026-08-03 in tax-related sell-to-cover transaction
Sale price
$85.3212 per share
Reported transaction price for the 1,070 shares of common stock
Shares held after
104,071 shares
Direct holdings of Dennis Cho following the reported sale
Net shares sold
1,070 shares
Net share change across all reported transactions in this Form 4
Key Terms
sell to cover, Restricted Stock Units, equity incentive plans, tax withholding obligations
4 terms
sell to cover financial
"funded by a "sell to cover" transaction and do not represent discretionary"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
Restricted Stock Units financial
"tax withholding obligations in connection with the vesting of Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
equity incentive plans financial
"Issuer's election under its equity incentive plans to require the satisfaction"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
tax withholding obligations financial
"shares required to be sold by the Reporting Person to cover tax withholding obligations"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Dennis Cho report at Twist Bioscience (TWST)?
Dennis Cho reported selling 1,070 shares of Twist Bioscience common stock at $85.3212 per share on 2026-08-03. The sale was tied to tax withholding obligations from vesting Restricted Stock Units under the company’s equity incentive plans.
Did Dennis Cho’s TWST transaction occur under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox was not affirmed, and the footnote instead explains the sale was mandated by the company’s equity plan as a sell-to-cover tax withholding transaction, rather than a pre-arranged trading plan.
What role does Dennis Cho hold at Twist Bioscience (TWST)?
Dennis Cho is identified as Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp. His Form 4 reflects a tax-related sell-to-cover sale of company shares connected to the vesting of Restricted Stock Units.